Skip to search formSkip to main contentSkip to account menu

Coronary thrombolysis

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Thrombolytic therapy for coronary aneurysm thrombosis of Kawasaki disease (KD) includes antiplatelet and anticoagulants, i.v… 
1992
1992
Excessive bleeding is a major concern during the administration of thrombolytic therapy. Although the great majority of these… 
Highly Cited
1990
Highly Cited
1990
Tissue plasminogen activator (tPA), an approved coronary thrombolytic agent, can cause serious bleeding. We report the cases of… 
Highly Cited
1989
Highly Cited
1989
Platelet activation is markedly increased during coronary thrombolysis and limits the response to thrombolytic therapy. A… 
Review
1989
Review
1989
ALTHOUGH the concept of coronary thrombolysis for the treatment of acute evolving myocardial infarction has been extant for over… 
Highly Cited
1987
Highly Cited
1987
Thirty-four patients with acute myocardial infarction were treated prospectively using a new strategy of prehospital intravenous… 
Review
1984
Review
1984
WHEN the editorial offices of Circulation moved to St. Louis, a series of "Perspectives" was initiated. The first, published in… 
1984
1984
Anterior ST segment depression, found in 13 of 17 patients with acute inferior myocardial infarctions, resolved promptly in all… 
Highly Cited
1982